Basic Grifulvin V Information

• INN (International Nonproprietary Name): Griseofulvin
• Brand Names Available In United Kingdom: not specified
• ATC Code: D01BA01
• Forms & Dosages: Tablets 125mg and 250mg; tablets 500mg in some regions; oral suspension 125mg/5ml in some regions
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription only (Rx)

Latest Research Highlights (Uk And Eu)

Worried that griseofulvin is outdated and no longer useful?

Recent UK and EU literature from 2022–2025 shows a clear trend away from routine griseofulvin use as newer azoles and allylamines take precedence.

Randomised trial meta-analyses indicate griseofulvin still works well for paediatric tinea capitis, with cure rates comparable to terbinafine in some child cohorts.

Average treatment durations were longer for griseofulvin and adult relapse rates appear higher than in paediatric groups.

Safety reviews using EU pharmacovigilance data report hepatic enzyme elevations and rare haematologic events linked to griseofulvin.

UK and EU regulatory summaries from Yellow Card and PRAC recommend careful liver monitoring in patients with pre-existing hepatic disease.

Clinicians interpreting trials should account for regional fungal epidemiology, since Trichophyton dominates UK tinea capitis while Microsporum is more common in parts of Europe.

Research takeaways for UK practice are that griseofulvin remains evidence-based for paediatric scalp infections but is less favoured in adults where terbinafine short courses fit NHS pressures better.

Clinical outcomes across trials and registries list cure rates and adverse events; clinicians should weigh trial size and local species prevalence when choosing therapy.

Clinical Effectiveness In The United Kingdom

Are you asking how well griseofulvin works in real NHS settings?

NHS practice reserves griseofulvin mainly for paediatric tinea capitis and selected recalcitrant dermatophyte infections when topical therapy fails.

Audit cycles in UK dermatology clinics report clinical clearance rates in children that match trial data for typical 4–6 week courses.

Adults often show slower improvement for skin and nail infections and higher relapse linked to poor adherence and untreated household reservoirs.

Typical regimens used in practice are 500mg–1g daily in adults and 10–20 mg/kg/day for children, with baseline liver function tests commonly recorded.

Community pharmacists provide counselling to support adherence, and electronic prescriptions plus GP follow-up help to track monitoring.

Cost-effectiveness is an issue for long courses, so many local formularies prefer terbinafine unless specific indications favour griseofulvin.

Patient-reported outcomes highlight concerns about treatment length and side effects, and pharmacy counselling often addresses these directly.

Indications And Expanded Uses

Want to know which infections griseofulvin treats best?

Systemic griseofulvin is indicated for dermatophyte infections, especially tinea capitis, corporis and cruris, and selected nail infections according to MHRA and NHS formularies.

Typical durations used in practice are 4–6 weeks for tinea capitis and longer courses for nail infections—fingernails often need at least four months and toenails six months or more.

Some private clinics use griseofulvin off-label in combination regimens for stubborn infections or where terbinafine and itraconazole are contraindicated.

Women of childbearing potential are advised to use effective contraception during and after therapy because griseofulvin is embryotoxic and teratogenic.

GPs commonly refer persistent or atypical cases to dermatology, while NHS 111 and pharmacist triage advise initial topical treatment when appropriate.

Below is a quick condition-to-dose guide used in UK practice.

• Tinea Capitis — Children: 10–20 mg/kg/day for 4–6 weeks.
• Tinea Corporis/Cruris — Adults: 500mg–1g daily for 2–4 weeks.
• Tinea Unguium — Adults: 500mg–1g daily for at least 4 months (fingernail) or 6 months (toenail).

Composition And Brand Landscape

Curious which brands and formulations are on the market?

The INN is griseofulvin and UK supply is mainly generics sourced from global manufacturers such as Teva and Sun Pharma.

International brand names include Grifulvin V, Fulvicin P/G and region-specific names like Griseofulvina and Griséofulvine, but UK-branded availability is not specified in the public dataset.

Common strengths internationally are 125mg and 250mg tablets, with 500mg tablets and oral suspensions available in some regions.

Microsize and ultramicrosize formulations differ in absorption, with microsize absorption improved when taken with a fatty meal.

Pharmacies such as Boots and LloydsPharmacy source generic griseofulvin, and prescribers generally request generic supply unless a specific brand is clinically required.

Packaging and excipient differences matter for patients with allergies, so pharmacists check product leaflets at supply.

Contraindications And Special Precautions

Are there patients who must not take griseofulvin?

Absolute contraindications include known hypersensitivity to griseofulvin, porphyria and severe hepatic failure.

Relative contraindications, where specialist oversight is advised, include pregnancy and lactation, a history of lupus, and significant hepatic or renal impairment.

Reported safety concerns include hepatic enzyme elevations, rare cases of leucopenia or granulocytopenia, photosensitivity and common GI effects such as nausea.

Clinicians in the UK typically perform baseline liver function tests and counsel women of childbearing age to use effective contraception during and after treatment.

Patients are advised to avoid excessive alcohol, take sun protection and stop the drug and seek urgent review if jaundice, severe rash, fever or unexplained bruising occur.

Community pharmacists routinely review concurrent medicines for interactions and reinforce monitoring instructions at supply.

Dosage Guidelines

How should griseofulvin be dosed for children and adults?

Standard NHS-aligned dosing for adults is 500mg–1g daily, given as a single dose or divided into two doses depending on tolerance.

Children receive weight-based dosing, typically 10–20 mg/kg/day, again as single or divided doses as advised by the prescriber.

Treatment durations vary by condition, from 4–6 weeks for tinea capitis to many months for nail infections.

Microsize versus ultramicrosize formulations affect absorption; advice to take with a fatty meal improves bioavailability, particularly for microsize tablets.

Missed-dose instructions are to take as soon as remembered unless it is near the next dose, and not to double doses.

Overdose requires urgent medical attention; symptoms may include nausea, vomiting and central nervous system effects.

Interactions Overview

Worried about your pill interacting with other medicines?

Griseofulvin is a hepatic enzyme inducer and can reduce the effectiveness of oral contraceptives and other drugs metabolised by CYP pathways.

Clinically important interacting classes include hormonal contraceptives, anticoagulants, certain antiepileptics and some psychotropic medications.

Co-prescribing with other hepatotoxic drugs increases the risk of liver injury and warrants extra caution.

Food increases absorption; in contrast, concurrent alcohol raises hepatic strain and should be avoided during therapy.

Pharmacists in the UK screen for interactions using electronic systems and advise alternative contraception or counselling about INR monitoring for patients on warfarin.

Patients should tell every healthcare provider they use griseofulvin to avoid unintended interactions.

Cultural Perceptions And Patient Habits

Do parents still trust griseofulvin for scalp ringworm?

Many UK parents prefer griseofulvin for paediatric tinea capitis because of historical familiarity and reassurance from school nursing or health visitors.

Younger adults often favour terbinafine for its shorter courses and convenience.

Online forums show confusion about long treatment durations and concerns about safety in children and fertility.

Community pharmacies and NHS 111 are common first contacts, and patients expect clear written information and counselling on contraception and side effects.

Practical tips that patients value include taking tablets with a fatty meal, sun protection advice and guidance on household decontamination to prevent reinfection.

Stigma around scalp infections in school-age children can delay presentation, so school nursing teams are important partners in local management pathways.

Availability And Pricing Patterns

How easy is it to get griseofulvin and what will it cost?

Griseofulvin is prescription-only and stocked variably by UK pharmacy chains; supply can be intermittent due to delistings in some EU markets.

Typical tablet strengths are 125mg and 250mg and oral suspension may be available from specific suppliers.

In England patients usually pay NHS prescription charges unless exempt, while Scotland, Wales and Northern Ireland have different prescription policies affecting out-of-pocket cost.

Online pharmacies offer convenience and wider access, and in our online pharmacy grifulvin v is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Clinicians are advised to check local formulary notes when prescribing and to communicate with the supplying pharmacy about expected delivery times and monitoring responsibilities.

Comparable Medicines And Preferences

Should griseofulvin be preferred over terbinafine or itraconazole?

Terbinafine is increasingly favoured in NHS formularies for many dermatophyte infections because it usually needs shorter courses and penetrates nail tissue well.

Itraconazole and fluconazole are alternatives depending on fungal species and patient factors such as liver function or drug interactions.

Griseofulvin remains strong for paediatric tinea capitis due to its keratin-targeting mechanism and established efficacy for scalp infections.

Weaknesses of griseofulvin include longer treatment durations, more drug interactions as a CYP inducer and teratogenicity concerns for women planning pregnancy.

Shared decision-making in primary care should document patient preferences, monitoring plans and possible specialist referral for recurrent or atypical infections.

Frequently Asked Questions

Can I take griseofulvin if I am pregnant or planning pregnancy?

No; griseofulvin is contraindicated in pregnancy and women should seek specialist advice before conception and use effective contraception during and after the course.

How long until I see improvement?

Scalp infections often need 4–6 weeks for clinical improvement, and nail infections can take many months before visible clearing occurs.

Will it interact with my contraceptive pill?

Yes; griseofulvin reduces hormonal contraceptive efficacy and alternative or additional contraception is recommended.

What monitoring is needed?

Baseline liver function tests and clinical monitoring for hepatic symptoms are standard; patients should report severe rash, fever or bleeding signs promptly.

When should I contact NHS services?

For urgent or worrying symptoms use NHS 111 or contact your local pharmacy; persistent or severe problems should prompt GP or dermatology review.

Guidelines For Proper Use

What should patients actually do when supplied griseofulvin?

Take the tablets with a fatty meal to improve absorption, and stick to the full course even if symptoms improve early.

Avoid alcohol and protect skin from excessive sunlight to reduce photosensitivity reactions.

Store medicine at room temperature in a dry place between 20–25°C and keep it out of reach of children.

Pharmacist counselling should include interaction checks, missed-dose advice and confirmation of weight-based dosing for children.

Household measures such as washing bedding, hair brushes and reducing shared hats or combs help prevent reinfection and are routinely recommended in UK practice.

Below is a short patient leaflet template that can be handed out in community pharmacy or attached to an electronic prescription.

• What It Is: An oral antifungal for certain skin, scalp and nail infections.
• How To Take: With food, preferably a fatty meal; follow the exact dose the prescriber gave.
• Side Effects: Nausea, headache, skin sensitivity to sunlight, and rarely liver issues or blood problems.
• Contraception Advice: Use reliable non-hormonal or additional contraception while taking griseofulvin.
• When To Seek Help: Jaundice, severe rash, fever, mouth ulcers or bleeding require prompt review.

Delivery Across United Kingdom

Final Practical Notes For Clinicians And Pharmacists

Document species when possible, since Trichophyton versus Microsporum influences drug choice.

Record baseline LFTs and contraception counselling in notes for women of childbearing potential.

Consider terbinafine for adults where formulary and species sensitivity permit, keeping griseofulvin for paediatric tinea capitis or specific contraindications to alternatives.

Use electronic prescribing to set monitoring reminders and ensure community pharmacists deliver targeted counselling on interactions and adherence.

Where supply is uncertain, discuss alternatives with local formulary teams and inform patients about realistic delivery times and monitoring responsibilities.